SE458338B - Farmaceutiska kompositioner med antineoplastisk aktivitet innefattande tvaavaert negativt selen och en alifatisk keton - Google Patents
Farmaceutiska kompositioner med antineoplastisk aktivitet innefattande tvaavaert negativt selen och en alifatisk ketonInfo
- Publication number
- SE458338B SE458338B SE8401234A SE8401234A SE458338B SE 458338 B SE458338 B SE 458338B SE 8401234 A SE8401234 A SE 8401234A SE 8401234 A SE8401234 A SE 8401234A SE 458338 B SE458338 B SE 458338B
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- compositions according
- contain
- negative
- antineoplastic activity
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 9
- 230000000118 anti-neoplastic effect Effects 0.000 title claims description 3
- 239000000203 mixture Substances 0.000 claims description 16
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 claims description 12
- 239000011669 selenium Substances 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 7
- 229910052711 selenium Inorganic materials 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 4
- 239000008159 sesame oil Substances 0.000 claims description 4
- 235000011803 sesame oil Nutrition 0.000 claims description 4
- ZUKYESOJWBQOFL-UHFFFAOYSA-N 1-(pentyldiselanyl)pentane Chemical compound CCCCC[Se][Se]CCCCC ZUKYESOJWBQOFL-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 claims description 2
- 150000001414 amino alcohols Chemical class 0.000 claims description 2
- XIMIGUBYDJDCKI-UHFFFAOYSA-N diselenium Chemical compound [Se]=[Se] XIMIGUBYDJDCKI-UHFFFAOYSA-N 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- IYTXKIXETAELAV-UHFFFAOYSA-N Aethyl-n-hexyl-keton Natural products CCCCCCC(=O)CC IYTXKIXETAELAV-UHFFFAOYSA-N 0.000 claims 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 1
- YNMZZHPSYMOGCI-UHFFFAOYSA-N Aethyl-octyl-keton Natural products CCCCCCCCC(=O)CC YNMZZHPSYMOGCI-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229960004050 aminobenzoic acid Drugs 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims 1
- 150000003959 diselenides Chemical class 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 231100000456 subacute toxicity Toxicity 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000295 fuel oil Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IMNMWRSFNRFWMA-UHFFFAOYSA-N 1-(undecyldiselanyl)undecane Chemical compound CCCCCCCCCCC[Se][Se]CCCCCCCCCCC IMNMWRSFNRFWMA-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 150000005415 aminobenzoic acids Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- -1 heptyl- Chemical group 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT19958/83A IT1161213B (it) | 1983-03-08 | 1983-03-08 | Composizioni farmaceutiche ad attivita' antineoplastica |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8401234D0 SE8401234D0 (sv) | 1984-03-06 |
| SE8401234L SE8401234L (sv) | 1984-09-09 |
| SE458338B true SE458338B (sv) | 1989-03-20 |
Family
ID=11162644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8401234A SE458338B (sv) | 1983-03-08 | 1984-03-06 | Farmaceutiska kompositioner med antineoplastisk aktivitet innefattande tvaavaert negativt selen och en alifatisk keton |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4681753A (da) |
| JP (1) | JPS59175427A (da) |
| AU (1) | AU556156B2 (da) |
| BE (1) | BE899090A (da) |
| CA (1) | CA1212330A (da) |
| CH (1) | CH661865A5 (da) |
| DE (1) | DE3408362C2 (da) |
| DK (1) | DK131884A (da) |
| FR (1) | FR2542614B1 (da) |
| GB (1) | GB2135885B (da) |
| IE (1) | IE57001B1 (da) |
| IL (1) | IL71178A (da) |
| IN (1) | IN159709B (da) |
| IT (1) | IT1161213B (da) |
| LU (1) | LU85238A1 (da) |
| NL (1) | NL8400722A (da) |
| NZ (1) | NZ207416A (da) |
| SE (1) | SE458338B (da) |
| ZA (1) | ZA841714B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH676667A5 (da) * | 1988-03-07 | 1991-02-28 | Onco Pharm Dev Ag | |
| WO1990003175A1 (en) * | 1988-09-27 | 1990-04-05 | Avram, Elena | Selenium compositions for treatment of disease |
| US5153221A (en) * | 1990-10-05 | 1992-10-06 | Elena Avram | Method for the treatment of acquired immune deficiency syndrome |
| DE4320694C2 (de) * | 1993-06-22 | 1999-11-11 | Biosyn Arzneimittel Gmbh | Vewendung von Selenverbindungen zur äußeren Anwendung bei Warzen |
| FR2757857B1 (fr) * | 1996-12-27 | 1999-04-23 | Oxis International Sa | Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques |
| AT412758B (de) * | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| US6867238B2 (en) | 2001-06-22 | 2005-03-15 | Gerhard N. Schrauzer | Compositions for the treatment and prevention of cancer |
| AT412703B (de) | 2001-12-04 | 2005-06-27 | Vis Vitalis Lizenz & Handels | Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung |
| US6632837B1 (en) * | 2002-10-21 | 2003-10-14 | Elena Avram | Compositions containing a selenium monobromide-oil reaction product and epichlorohydrin and methods of making the same |
| AT511159A1 (de) | 2011-02-16 | 2012-09-15 | Selo Medical Gmbh | Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4564634A (en) * | 1982-05-28 | 1986-01-14 | F.C.N.S.R.L. | Selenium compounds having antineoplastic activity, process for the preparation thereof and pharmaceutical compositions therefrom |
-
1983
- 1983-03-08 IT IT19958/83A patent/IT1161213B/it active
-
1984
- 1984-02-29 DK DK131884A patent/DK131884A/da not_active Application Discontinuation
- 1984-03-01 IE IE487/84A patent/IE57001B1/xx unknown
- 1984-03-02 US US06/585,855 patent/US4681753A/en not_active Expired - Fee Related
- 1984-03-02 CH CH1040/84A patent/CH661865A5/it not_active IP Right Cessation
- 1984-03-05 CA CA000448826A patent/CA1212330A/en not_active Expired
- 1984-03-06 SE SE8401234A patent/SE458338B/sv not_active IP Right Cessation
- 1984-03-06 NL NL8400722A patent/NL8400722A/nl not_active Application Discontinuation
- 1984-03-07 LU LU85238A patent/LU85238A1/fr unknown
- 1984-03-07 NZ NZ207416A patent/NZ207416A/en unknown
- 1984-03-07 IL IL71178A patent/IL71178A/xx unknown
- 1984-03-07 FR FR8403513A patent/FR2542614B1/fr not_active Expired
- 1984-03-07 BE BE2060358A patent/BE899090A/nl unknown
- 1984-03-07 DE DE3408362A patent/DE3408362C2/de not_active Expired
- 1984-03-08 ZA ZA841714A patent/ZA841714B/xx unknown
- 1984-03-08 GB GB08406132A patent/GB2135885B/en not_active Expired
- 1984-03-08 AU AU25422/84A patent/AU556156B2/en not_active Ceased
- 1984-03-08 JP JP59045366A patent/JPS59175427A/ja active Pending
- 1984-03-08 IN IN145/MAS/84A patent/IN159709B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL8400722A (nl) | 1984-10-01 |
| DE3408362A1 (de) | 1984-09-13 |
| ZA841714B (en) | 1984-10-31 |
| LU85238A1 (fr) | 1984-09-24 |
| GB2135885A (en) | 1984-09-12 |
| SE8401234L (sv) | 1984-09-09 |
| IN159709B (da) | 1987-06-06 |
| IE57001B1 (en) | 1992-03-11 |
| IL71178A (en) | 1987-11-30 |
| FR2542614B1 (fr) | 1987-03-20 |
| SE8401234D0 (sv) | 1984-03-06 |
| IE840487L (en) | 1984-09-08 |
| IT1161213B (it) | 1987-03-18 |
| DK131884A (da) | 1984-09-09 |
| CA1212330A (en) | 1986-10-07 |
| GB2135885B (en) | 1986-09-10 |
| BE899090A (nl) | 1984-07-02 |
| US4681753A (en) | 1987-07-21 |
| CH661865A5 (it) | 1987-08-31 |
| DK131884D0 (da) | 1984-02-29 |
| NZ207416A (en) | 1986-10-08 |
| AU556156B2 (en) | 1986-10-23 |
| GB8406132D0 (en) | 1984-04-11 |
| AU2542284A (en) | 1984-09-13 |
| FR2542614A1 (fr) | 1984-09-21 |
| JPS59175427A (ja) | 1984-10-04 |
| IT8319958A0 (it) | 1983-03-08 |
| DE3408362C2 (de) | 1987-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60202278T2 (de) | Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten | |
| EP0339237A3 (en) | Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them | |
| KR910002802A (ko) | 1,2,3,4-테트라히드로-9-아크리딘아민의 유도체 | |
| US20150353467A1 (en) | 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof | |
| MC349A1 (fr) | Perfectionnements aux compositions contenant des antibiotiques à base de tétracycline | |
| ZA826408B (en) | S-adenosylmethionine derivatives the process for their preparation and thereapeutic compositions which contain them as active principle | |
| HU221498B (en) | Pharmaceutical compositions containing quinoxaline derivative and nucleoside derivative synergic combinations | |
| CH661865A5 (it) | Composizioni farmaceutiche ad attivita antineoplastica. | |
| GR78771B (da) | ||
| KR927003537A (ko) | 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도 | |
| ATE25849T1 (de) | Tricyclophosphazen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| SE8304410D0 (sv) | Cyklohexylkarboxylsyraderivat och sett for deras framstellning | |
| JP3824319B2 (ja) | 抗ウイルス作用組成物 | |
| JP2625199B2 (ja) | 抗腫瘍性組成物 | |
| ATE19244T1 (de) | 2-piperazinyl-4-phenyl-quinazolin-derivate mit antidepressiven eigenschaften, verfahren zu deren herstellung und diese enthaltende arzneimitteln. | |
| GB1475346A (en) | L-arginine derivatives | |
| EP2736960A1 (de) | Abtrennung von cyclischen siloxanen aus kurzkettigen siloxanen mit endständigen hydroxylgruppen | |
| SE466400B (sv) | 3-(2-haloalkyl)-1,4-oxatiiner och 2-(2-haloalkyl)1,4-ditiiner och bahandling av leukemi och tumoerer daermed | |
| IL21955A (en) | Salts of fusidic acid and antibiotics of the tetracycline series | |
| KR940009201A (ko) | V족 주그룹의 원자량이 큰 원소를 함유하는 인지질 유도체 | |
| DE3017026A1 (de) | Isoprenylamine und ihre saeureadditionssalze sowie sie enthaltende antivirus-mittel fuer wirbeltiere | |
| KR950700068A (ko) | 치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds) | |
| ATE270T1 (de) | Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. | |
| WO1994016695A1 (en) | Pharmaceutical compositions containing cimetidine | |
| KR970061875A (ko) | 신규 항바이러스성 6위치에 치환된 피리미딘디온 호모 카보사이클릭 뉴클레오시드 유도체 및 그의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8401234-3 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8401234-3 Format of ref document f/p: F |